MED16 and cancer: Moreover, c-MYC and CCND1 are markers of cancer cell proliferation and cell cycle progression, and western blotting showed that the expression of c-MYC and CCND1 was higher in the MED16 overexpression group (Figure 3G and Supplementary Figure S3C).